Personalized approaches for treatment-naïve mantle cell lymphoma.
David A QuallsAnita KumarPublished in: Expert review of hematology (2023)
Given the wide array of disease and patient presentations with MCL, a personalized therapeutic approach is needed to optimize outcomes. The best therapeutic strategy should incorporate disease prognostic factors, patient status and comorbidities, goals of care, and response to treatment.